"Amodiaquine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-aminoquinoline compound with anti-inflammatory properties.
| Descriptor ID |
D000655
|
| MeSH Number(s) |
D03.633.100.810.050.060
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amodiaquine".
Below are MeSH descriptors whose meaning is more specific than "Amodiaquine".
This graph shows the total number of publications written about "Amodiaquine" by people in this website by year, and whether "Amodiaquine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Amodiaquine" by people in Profiles.
-
Treatment of COVID-19 with Chloroquine: Implication for Malaria Chemotherapy Using ACTs in Disease Endemic Countries. J Trop Pediatr. 2021 01 29; 67(1).
-
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. Int J Infect Dis. 2020 Oct; 99:437-440.
-
Potential Antiviral Options against SARS-CoV-2 Infection. Viruses. 2020 06 13; 12(6).
-
Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations. Int J Mol Sci. 2020 May 30; 21(11).
-
Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage. Int J Antimicrob Agents. 2020 Jun; 55(6):105964.
-
Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo. Int J Infect Dis. 2019 Aug; 85:49-53.
-
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis. 2019 May 02; 19(1):376.
-
High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain. Cell Stem Cell. 2017 08 03; 21(2):274-283.e5.
-
Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria. Am J Trop Med Hyg. 2017 Aug; 97(2):514-525.
-
Busting the billion-dollar myth: how to slash the cost of drug development. Nature. 2016 08 25; 536(7617):388-90.